A
Adlai Nortye Ltd
NASDAQ:ANL
Adlai Nortye Ltd
NASDAQ:ANL
Price:
11.16
USD
-7%
Market Closed
Market Cap:
$411.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Adlai Nortye Ltd
NASDAQ:ANL
|
KY |
|
M
|
Matinas BioPharma Holdings Inc
AMEX:MTNB
|
US |
Income Statement
Earnings Waterfall
Adlai Nortye Ltd
Adlai Nortye Ltd
Income Statement
Adlai Nortye Ltd
Adlai Nortye Ltd
Currency: USD
| Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|
| Revenue | ||||||
| Interest Expense |
0
|
1
|
0
|
2
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
| Operating Income | ||||||
| Operating Expenses |
(99)
|
(73)
|
(102)
|
(53)
|
(72)
|
|
| Selling, General & Administrative |
(18)
|
(15)
|
(20)
|
(9)
|
(14)
|
|
| Research & Development |
(82)
|
(56)
|
(84)
|
(44)
|
(60)
|
|
| Depreciation & Amortization |
0
|
(2)
|
0
|
(2)
|
0
|
|
| Other Operating Expenses |
1
|
1
|
2
|
2
|
2
|
|
| Operating Income |
(99)
N/A
|
(73)
+27%
|
(102)
-40%
|
(53)
+48%
|
(72)
-36%
|
|
| Pre-Tax Income | ||||||
| Interest Income Expense |
(38)
|
(40)
|
(41)
|
(2)
|
(3)
|
|
| Total Other Income |
0
|
3
|
6
|
3
|
4
|
|
| Pre-Tax Income |
(137)
N/A
|
(109)
+20%
|
(137)
-25%
|
(52)
+62%
|
(70)
-35%
|
|
| Net Income | ||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(137)
|
(109)
|
(137)
|
(52)
|
(70)
|
|
| Net Income (Common) |
(137)
N/A
|
(109)
+20%
|
(137)
-25%
|
(52)
+62%
|
(70)
-35%
|
|
| EPS (Diluted) |
-1.22
N/A
|
-2.52
-107%
|
-1.74
+31%
|
-0.54
+69%
|
-0.73
-35%
|
|
Switch to:
Switch to:
See Also
Discover More
